| PERIOD ENDING | 31-Jan-09 | 31-Jan-08 | 31-Jan-07 | | Total Revenue | 249,667 | 272,676 | 258,589 | | Cost of Revenue | 114,645 | 152,261 | 172,389 | | | Gross Profit | 135,022 | 120,415 | 86,200 | | | Operating Expenses | | Research Development | 62,083 | 58,780 | 50,728 | | Selling General and Administrative | 73,913 | 97,991 | 87,768 | | Non Recurring | (87,811) |
-
|
-
| | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | 86,837 | (36,356) | (52,296) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 18,636 | 5,031 | 4,767 | | Earnings Before Interest And Taxes | 105,473 | (31,325) | (47,529) | | Interest Expense | 553 | 102 | 173 | | Income Before Tax | 104,920 | (31,427) | (47,702) | | Income Tax Expense | 1,328 | 30 | 52 | | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | 103,592 | (31,457) | (47,754) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | 103,592 | (31,457) | (47,754) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $103,592 | ($31,457) | ($47,754) |
|
1.29% Nasdaq 0.00%
Income Statement
